MetLife, Inc. (MET) P/E Ratio History
Premium ValuationTrading at 20.3x vs 5Y avg 15.6x · 85th percentile · Premium to historical baseline · Data 2000–2026
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, MetLife, Inc. (MET) trades at a price-to-earnings ratio of 20.3x, with a stock price of $97.20 and trailing twelve-month earnings per share of $5.53.
The current P/E is 30% above its 5-year average of 15.6x. Over the past five years, MET's P/E has ranged from a low of 7.9x to a high of 36.2x, placing the current valuation at the 85th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.9x, MET trades at a 45% premium to its sector peers. The sector includes 804 companies with P/E ratios ranging from 0.0x to 157.5x.
Relative to the broader market, MET trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MET DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MET Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
MET P/E vs Peers
Diversified global life and asset managers peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $41B | 11.5 | - | +36% | |
| $8B | 7.0Lowest | 0.39Best | -68% | |
| $15B | 22.1 | 11.44 | -55% | |
| $25B | 21.7 | - | -21% | |
| $4B | 17.8 | - | -21% | |
| $59B | 16.9 | - | -29% | |
| $13B | 12.0 | 0.77 | +18% | |
| $5B | 23.0 | 10.55 | -37% | |
| $40B | 13.9 | - | +62%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
MET Historical P/E Data (2000–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $84.61 | $5.21 | 16.2x | -19% |
| FY2026 Q1 | - | $70.72 | $5.16 | 13.7x | -32% |
| FY2025 Q4 | Dec 31 2025 | $78.94 | $4.70 | 16.8x | -16% |
| FY2025 Q3 | - | $82.37 | $5.31 | 15.5x | -23% |
| FY2025 Q2 | Jun 30 2025 | $80.42 | $5.90 | 13.6x | -32% |
| FY2025 Q1 | Mar 31 2025 | $80.29 | $6.15 | 13.1x | -35% |
| FY2024 Q4 | - | $81.88 | $5.97 | 13.7x | -32% |
| FY2024 Q3 | Sep 30 2024 | $82.48 | $4.96 | 16.6x | -17% |
| FY2024 Q2 | Jun 30 2024 | $70.19 | $3.71 | 18.9x | -6% |
| FY2024 Q1 | Mar 31 2024 | $74.11 | $2.91 | 25.5x | +27% |
| FY2023 Q4 | Dec 31 2023 | $66.13 | $1.83 | 36.2x | +80% |
| FY2023 Q3 | Sep 30 2023 | $62.91 | $2.72 | 23.1x | +15% |
| FY2023 Q2 | Jun 30 2023 | $56.53 | $3.53 | 16.0x | -20% |
| FY2023 Q1 | Mar 31 2023 | $57.94 | $4.13 | 14.0x | -30% |
| FY2022 Q4 | Dec 31 2022 | $72.37 | $6.00 | 12.1x | -40% |
| FY2022 Q3 | Sep 30 2022 | $60.78 | $5.73 | 10.6x | -47% |
| FY2022 Q2 | - | $62.79 | $6.13 | 10.2x | -49% |
| FY2022 Q1 | - | $70.28 | $8.88 | 7.9x | -61% |
| FY2021 Q4 | Dec 31 2021 | $62.49 | $7.32 | 8.5x | -58% |
| FY2021 Q3 | - | $61.73 | $6.07 | 10.2x | -49% |
| FY2021 Q2 | Jun 30 2021 | $59.85 | $4.99 | 12.0x | -40% |
| FY2021 Q1 | Mar 31 2021 | $60.79 | $1.23 | 49.2x | +145% |
| FY2020 Q4 | - | $46.95 | $5.65 | 8.3x | -59% |
| FY2020 Q3 | Sep 30 2020 | $37.17 | $6.09 | 6.1x | -70% |
| FY2020 Q2 | - | $36.52 | $7.70 | 4.7x | -76% |
| FY2020 Q1 | - | $30.57 | $9.40 | 3.3x | -84% |
| FY2019 Q4 | - | $50.97 | $6.05 | 8.4x | -58% |
| FY2019 Q3 | Sep 30 2019 | $47.16 | $7.51 | 6.3x | -69% |
| FY2019 Q2 | Jun 30 2019 | $49.67 | $6.09 | 8.2x | -59% |
| FY2019 Q1 | Mar 31 2019 | $42.57 | $5.15 | 8.3x | -59% |
| FY2018 Q4 | Dec 31 2018 | $41.06 | $4.94 | 8.3x | -59% |
| FY2018 Q3 | Sep 30 2018 | $46.72 | $5.04 | 9.3x | -54% |
| FY2018 Q2 | Jun 30 2018 | $43.60 | $4.08 | 10.7x | -47% |
| FY2018 Q1 | Mar 31 2018 | $45.89 | $4.05 | 11.3x | -44% |
| FY2017 Q4 | Dec 31 2017 | $50.56 | $3.61 | 14.0x | -30% |
| FY2017 Q2 | Jun 30 2017 | $48.96 | $0.12 | 408.0x | +1929% |
| FY2017 Q1 | Mar 31 2017 | $47.07 | $0.22 | 214.0x | +964% |
| FY2016 Q4 | Dec 31 2016 | $48.02 | $1.45 | 33.1x | +65% |
| FY2016 Q3 | Sep 30 2016 | $39.59 | $4.09 | 9.7x | -52% |
| FY2016 Q2 | - | $35.49 | $4.64 | 7.6x | -62% |
| FY2016 Q1 | - | $39.16 | $4.66 | 8.4x | -58% |
| FY2015 Q4 | - | $42.96 | $4.55 | 9.4x | -53% |
| FY2015 Q3 | Sep 30 2015 | $42.02 | $5.15 | 8.2x | -59% |
| FY2015 Q2 | - | $49.90 | $5.90 | 8.5x | -58% |
| FY2015 Q1 | - | $45.05 | $6.15 | 7.3x | -64% |
| FY2014 Q4 | Dec 31 2014 | $48.20 | $5.42 | 8.9x | -56% |
| FY2014 Q3 | - | $47.87 | $4.89 | 9.8x | -51% |
| FY2014 Q2 | Jun 30 2014 | $49.51 | $3.92 | 12.6x | -37% |
| FY2014 Q1 | Mar 31 2014 | $47.05 | $3.18 | 14.8x | -26% |
| FY2013 Q4 | - | $48.05 | $2.91 | 16.5x | -18% |
| FY2013 Q3 | Sep 30 2013 | $41.84 | $2.23 | 18.8x | -7% |
| FY2013 Q2 | Jun 30 2013 | $40.78 | $0.47 | 87.1x | +333% |
| FY2013 Q1 | Mar 31 2013 | $33.88 | $2.16 | 15.7x | -22% |
| FY2012 Q4 | Dec 31 2012 | $29.35 | $1.13 | 26.0x | +29% |
| FY2012 Q3 | Sep 30 2012 | $30.71 | $0.86 | 35.7x | +78% |
| FY2012 Q2 | Jun 30 2012 | $27.49 | $5.11 | 5.4x | -73% |
| FY2012 Q1 | Mar 31 2012 | $33.28 | $4.12 | 8.1x | -60% |
| FY2011 Q4 | Dec 31 2011 | $27.79 | $5.06 | 5.5x | -73% |
| FY2011 Q3 | Sep 30 2011 | $24.96 | $6.06 | 4.1x | -80% |
| FY2011 Q2 | - | $39.09 | $3.05 | 12.8x | -36% |
| FY2011 Q1 | - | $39.86 | $3.76 | 10.6x | -47% |
| FY2010 Q4 | Dec 31 2010 | $39.60 | $3.95 | 10.0x | -50% |
| FY2010 Q3 | - | $34.26 | $3.48 | 9.8x | -51% |
| FY2010 Q2 | Jun 30 2010 | $33.65 | $2.37 | 14.2x | -29% |
| FY2009 Q1 | - | $20.29 | $2.34 | 8.7x | -57% |
| FY2008 Q4 | Dec 31 2008 | $31.07 | $3.89 | 8.0x | -60% |
| FY2008 Q3 | - | $49.90 | $4.36 | 11.4x | -43% |
| FY2008 Q2 | Jun 30 2008 | $47.03 | $4.82 | 9.8x | -51% |
| FY2008 Q1 | Mar 31 2008 | $53.70 | $5.04 | 10.7x | -47% |
| FY2007 Q4 | Dec 31 2007 | $54.91 | $5.48 | 10.0x | -50% |
| FY2007 Q3 | Sep 30 2007 | $62.14 | $9.02 | 6.9x | -66% |
| FY2007 Q2 | Jun 30 2007 | $57.46 | $9.02 | 6.4x | -68% |
| FY2007 Q1 | Mar 31 2007 | $56.28 | $8.34 | 6.7x | -66% |
| FY2006 Q4 | Dec 31 2006 | $52.59 | $7.99 | 6.6x | -67% |
| FY2006 Q3 | Sep 30 2006 | $50.51 | $3.86 | 13.1x | -35% |
| FY2006 Q2 | Jun 30 2006 | $45.64 | $3.54 | 12.9x | -36% |
| FY2006 Q1 | Mar 31 2006 | $43.10 | $5.76 | 7.5x | -63% |
| FY2005 Q4 | Dec 31 2005 | $43.67 | $6.16 | 7.1x | -65% |
| FY2005 Q3 | Sep 30 2005 | $44.41 | $6.00 | 7.4x | -63% |
| FY2005 Q2 | - | $40.05 | $5.95 | 6.7x | -67% |
| FY2005 Q1 | - | $34.84 | $4.19 | 8.3x | -59% |
| FY2004 Q4 | Dec 31 2004 | $36.10 | $3.65 | 9.9x | -51% |
| FY2004 Q3 | - | $34.44 | $3.90 | 8.8x | -56% |
| FY2004 Q2 | Jun 30 2004 | $31.95 | $3.73 | 8.6x | -57% |
| FY2004 Q1 | Mar 31 2004 | $31.80 | $3.26 | 9.8x | -51% |
| FY2003 Q4 | Dec 31 2003 | $30.00 | $2.94 | 10.2x | -49% |
| FY2003 Q3 | - | $25.00 | $2.81 | 8.9x | -56% |
| FY2003 Q2 | Jun 30 2003 | $25.24 | $2.51 | 10.1x | -50% |
| FY2003 Q1 | Mar 31 2003 | $23.51 | $2.23 | 10.5x | -48% |
| FY2002 Q4 | - | $24.10 | $2.20 | 11.0x | -46% |
| FY2002 Q3 | Sep 30 2002 | $20.28 | $1.03 | 19.7x | -2% |
| FY2002 Q2 | Jun 30 2002 | $25.67 | $0.79 | 32.5x | +62% |
| FY2002 Q1 | Mar 31 2002 | $28.07 | $0.69 | 40.7x | +102% |
| FY2001 Q4 | Dec 31 2001 | $28.23 | $0.62 | 45.5x | +126% |
| FY2001 Q3 | Sep 30 2001 | $26.47 | $2.02 | 13.1x | -35% |
| FY2001 Q2 | Jun 30 2001 | $27.61 | $2.12 | 13.0x | -35% |
| FY2001 Q1 | Mar 31 2001 | $26.78 | $1.56 | 17.2x | -15% |
| FY2000 Q4 | Dec 31 2000 | $31.19 | $1.49 | 20.9x | +4% |
| FY2000 Q3 | Sep 30 2000 | $23.34 | $0.82 | 28.5x | +42% |
| FY2000 Q2 | Jun 30 2000 | $18.77 | $0.83 | 22.6x | +12% |
Average P/E for displayed period: 20.1x
MET Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MET — Frequently Asked Questions
Quick answers to the most common questions about buying MET stock.
What is MET's P/E ratio?
MetLife, Inc. (MET) trailing twelve-month P/E ratio is 20.3x, based on TTM diluted EPS of $5.53. The 5-year average P/E is 15.6x and the historical range spans 7.9x to 36.2x.
Is MET stock overvalued or undervalued?
MET trades at 20.3x P/E, above its 5-year average of 15.6x. The 85th percentile ranking within the 7.9x–36.2x historical range indicates a premium to historical valuation.
Is MET stock expensive?
Yes, MET is expensive relative to its own history. The current P/E of 20.3x is above the 5-year average of 15.6x and also above the Financial Services sector median of 13.9x. The stock sits at the 85th percentile of its 5-year valuation range.
What is MET's historical P/E range?
Over the past 5 years, MET's P/E ratio has ranged from 7.9x to 36.2x, with a median of 14.0x and an average of 15.6x. The current P/E of 20.3x places the stock at the 85th percentile of this range. Full historical data spans 2000–2026.
How does MET's P/E compare to the S&P 500?
MET trades at 20.3x P/E versus the S&P 500 median of 25.3x. The 20% discount to the market suggests lower growth expectations or perceived higher risk.
How does MET's valuation compare to Financial Services peers?
MetLife, Inc. P/E of 20.3x compares to the Financial Services sector median of 13.9x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is MET's PEG ratio?
MET PEG ratio is N/A, based on a P/E of 20.3x and EPS growth of -19.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is MET's earnings yield?
MET earnings yield is 4.94%, the inverse of its 20.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.